ArticleOncotarget2017
Rapamycin sensitizes cancer cells to growth inhibition by the PARP inhibitor olaparib.
Atsushi Osoegawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleOncotarget2017
Atsushi Osoegawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.